-
Using the Chemical Modification of Alpha-synuclein to Define Disease State and Facilitate Patient Stratification in Parkinson’s Disease
… to discriminate between PD, Dementia with Lewy body (DLB), Multiple system atrophy (MSA) and healthy controls, which will allow us to …
-
Maximizing the Sensitivity of Seed Amplification Assays Used to Detect Alpha-synuclein Aggregates
… but distinguishable protein aggregates involved in PD and multiple systems atrophy (MSA). Impact on Diagnosis/Treatment of Parkinson’s …
-
Episode 10: Understanding Genetics, Pathology, and Progression in Parkinson's Disease and Atypical Parkinsonian Syndromes with Huw Morris
March 5, 2024
… Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia …
-
Blood Test May Help Confirm Parkinson's Diagnosis
February 14, 2017
… certain atypical parkinsonisms (corticobasal degeneration, multiple system atrophy and progressive supranuclear palsy). Researchers …
-
Interrogating Novel Defects in Protein Glycosylation in GBA1-associated Parkinson’s Disease
… profiles (including progressive supranuclear palsy and multiple system atrophy) and standardization of assays across the field. …
-
Maximizing Sensitivity of Alpha-synuclein Seed Amplification Assays by Eliminating Spontaneous Aggregation
… aggregates of a similar, but distinguishable type: PD and multiple systems atrophy (MSA). Impact on Diagnosis/Treatment of Parkinson’s …